Martenet A C, Paccolat F
Ophtalmologie. 1989 Jan-Mar;3(1):40-2.
We present middle and long-term results of cyclophosphamide and procarbazine therapy of Behçet's uveitis. Of 45 patients, 20 were followed for 1-4 years (14 successful cases, 5 satisfactory results with regression of inflammatory signs but no functional improvement, 1 failure), 17 for 5-10 years (9 successes, 5 satisfactory results, 3 failures), and 8 for 11-16 years (2 successes, 2 satisfactory results, 4 failures). The high percentage of success (over 55%) could be attributed partly to the early onset of therapy and may be partly to the choice of drugs.
我们展示了环磷酰胺和丙卡巴肼治疗白塞氏葡萄膜炎的中长期结果。45例患者中，20例随访了1至4年（14例成功，5例炎症体征消退但功能无改善的满意结果，1例失败），17例随访了5至10年（9例成功，5例满意结果，3例失败），8例随访了11至16年（2例成功，2例满意结果，4例失败）。高成功率（超过55%）部分可归因于治疗开始早，部分可能归因于药物选择。
